9Suppliers
2Customers
3Debt Items
20Related Chains

Nautilus Biotechnology, Inc. Suppliers

TickerNameConfidenceEvidence
AMGN Amgen Inc. 90% In October 2021, we entered into a research collaboration agreement with Amgen in which the Nautilus platform may be used across a number of projects
AMGN Amgen Inc. 90% Reciprocal relationship from AMGN graph: Reciprocal relationship from NAUT graph: In October 2021, we entered into a research collaboration agreement with Amgen in which the Nautilus platform may be …
GENENTECH GENENTECH 90% In December of 2020, we signed a research collaboration agreement with Genentech to engage in a pilot study using our technology
SINGLE-SOURCE-SUPPLIERS SINGLE-SOURCE-SUPPLIERS 90% The Company relies on single source suppliers for certain components and materials used in the Nautilus Voyager TM platform.
THE-BUCK-INSTITUTE-FOR-RESEARCH-ON-AGING THE-BUCK-INSTITUTE-FOR-RESEARCH-ON-AGING 90% In February of 2025, we entered into a research collaboration with The Buck Institute for Research on Aging where the Nautilus platform may be used across a number of projects
THE-UNIVERSITY-OF-TEXAS-MD-ANDERSON-CANCER-CENTE THE-UNIVERSITY-OF-TEXAS-MD-ANDERSON-CANCER-CENTE 90% In October 2021, we signed a research agreement with The University of Texas MD Anderson Cancer Center
VENDORS VENDORS 90% The Company relies, and expects to continue to rely, on a number of vendors to provide services, supplies and materials related to its research and development programs.
BDX Becton, Dickinson and Company 72% stems will provide. We aim to build long-term loyalty with our customers by enhancing their individual research programs, enabling their successes, and driving growth within their organizations throu…
BDX Becton, Dickinson and Company 72% Reciprocal relationship from BDX graph: Reciprocal relationship from NAUT graph: stems will provide. We aim to build long-term loyalty with our customers by enhancing their individual research progra…

Nautilus Biotechnology, Inc. Customers

TickerNameConfidenceEvidence
BDX Becton, Dickinson and Company 72% oyager instrument automates the Nautilus assay chemistry concurrent with rapid optical imaging of the flow cell. The current system is an early-stage design, used for optimization of the function and…
BDX Becton, Dickinson and Company 72% Reciprocal relationship from BDX graph: Reciprocal relationship from NAUT graph: Reciprocal relationship from BDX graph: Reciprocal relationship from NAUT graph: Reciprocal relationship from BDX grap…

Nautilus Biotechnology, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
NAUT-DEBT-11170 Xbrl Convertible 90% xbrl convertible detail from xbrl 2021-12-31.
NAUT-DEBT-11169 Warrants outstanding: 0 90% xbrl warrant detail from xbrl 2021-12-31.
NAUT-DEBT Debt stack $28.9M 90% Market cache reports total debt of $28.9M.

Nautilus Biotechnology, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Nautilus Biotechnology, Inc..

Nautilus Biotechnology, Inc. Ownership

HolderNameConfidenceEvidence
NAUT-OWNER-PERCEPTIVE-ADVISORS-LLC PERCEPTIVE ADVISORS LLC 90% 13F overlay lists PERCEPTIVE ADVISORS LLC as top holder; 84 tracked holders.

Nautilus Biotechnology, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CTKB Cytek Biosciences, Inc. 100.00 2
AORT Artivion, Inc. 100.00 2
AMGN Amgen Inc. 100.00 1 ['supplier']
ANGO AngioDynamics, Inc. 100.00 2
EW Edwards Lifesciences Corporation 100.00 2
HBIO Harvard Bioscience, Inc. 100.00 2
EMBC Embecta Corp. 100.00 2
WAT Waters Corporation 100.00 2
IINN Inspira Technologies Oxy B.H.N. Ltd. 100.00 2
PYPD PolyPid Ltd. 100.00 2
CDNA CareDx, Inc. 100.00 2
TELA TELA Bio, Inc. 100.00 2
ONC BeOne Medicines AG 50.00 2
MMSI Merit Medical Systems, Inc. 50.00 2
NMRA Neumora Therapeutics, Inc. 50.00 2
ARWR Arrowhead Pharmaceuticals, Inc. 50.00 2
CUZ Cousins Properties Incorporated 50.00 2
WATERS WATERS 50.00 2
CTMX CytomX Therapeutics, Inc. 50.00 2
PODD Insulet Corporation 50.00 2